Flinton Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$172K Buy
8,976
+1,424
+19% +$33.4K 0.01% 692
2019
Q2
$166K Hold
7,552
0.01% 720
2019
Q1
$155K Buy
+7,552
New +$131K 0.01% 716

Other funds holding NEO

Flinton Capital Management's NEO Position: Q3 2019 in Review

Flinton Capital Management increased its NeoGenomics (NEO) stake by 19% in Q3 2019, buying an estimated $33.4K and bringing the position to 8,976 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #692.

Flinton Capital Management first reported a position in NEO in Q1 2019 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

  • Flinton Capital Management held 8,976 shares of NeoGenomics worth $172K as of Q3 2019.
  • Flinton Capital Management bought 1,424 NeoGenomics shares in Q3 2019, an estimated $33.4K.
  • NeoGenomics made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #692 holding.
  • Flinton Capital Management first reported a position in NeoGenomics in Q1 2019 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.